Cannabis Capsule Market Report 2026
Global Outlook – By Type (High Tetrahydrocannabinol Capsules, Tetrahydrocannabinol Or Cannabinol Balance Capsule, High Cannabinol Capsules), By Compound (Tetrahydrocannabinol (THC)-Dominant, Cannabidiol (CBD)-Dominant), By End User (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Sales) – Market Size, Trends, Strategies, and Forecast to 2030
Cannabis Capsule Market Overview
• Cannabis Capsule market size has reached to $46.98 billion in 2025 • Expected to grow to $108.48 billion in 2030 at a compound annual growth rate (CAGR) of 18.2% • Growth Driver: Cannabis Capsule Market Surges As CBD Shows Potential Benefits For Addressing Neurological Disorders • Market Trend: Increasing Focus On Introducing The First Oral Cannabis Capsule Tailored For Chronic Pain Relief • North America was the largest region in 2025.What Is Covered Under Cannabis Capsule Market?
A cannabis capsule, or marijuana pill, refers to a psychoactive substance that contains single cannabinoids, such as THC (tetrahydrocannabinol), CBD (cannabidiol), or the full spectrum of compounds present in the source cannabis plant. It is used for both medical and recreational purposes, including relief from restlessness, muscle contractions, and chronic discomfort, as well as a reduction in vomiting and illness caused by chemotherapy. The main types of cannabis capsules are high-tetrahydrocannabinol capsules, tetrahydrocannabinol or cannabinol balance capsules, and high-cannabinol capsules. High-tetrahydrocannabinol (THC) capsules are oral capsules that contain a high concentration of THC, the main psychoactive compound found in cannabis. Various types of compounds are included, such as tetrahydrocannabinol (THC)-dominant and cannabidiol (CBD)-dominant, which are used by several end users, including hospital pharmacies, retail pharmacies, drug stores, and online sales.
What Is The Cannabis Capsule Market Size and Share 2026?
The cannabis capsule market size has grown rapidly in recent years. It will grow from $46.98 billion in 2025 to $55.59 billion in 2026 at a compound annual growth rate (CAGR) of 18.3%. The growth in the historic period can be attributed to increasing awareness of medical cannabis benefits, legalization of cannabis in select regions, growing preference for alternative therapies, rising incidence of chronic pain and nausea, advancements in capsule formulation technology.What Is The Cannabis Capsule Market Growth Forecast?
The cannabis capsule market size is expected to see rapid growth in the next few years. It will grow to $108.48 billion in 2030 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to expansion of legal cannabis markets globally, development of targeted cannabinoid therapies, technological advancements in encapsulation, increased adoption in hospital and retail pharmacies, growing consumer acceptance of wellness-oriented cannabis products. Major trends in the forecast period include personalized cannabinoid therapy, enhanced drug delivery systems, rising medical cannabis acceptance, growth in online pharmacies & e-commerce, regulatory standardization across regions.
Global Cannabis Capsule Market Segmentation
1) By Type: High Tetrahydrocannabinol Capsules, Tetrahydrocannabinol Or Cannabinol Balance Capsule, High Cannabinol Capsules 2) By Compound: Tetrahydrocannabinol (THC)-Dominant, Cannabidiol (CBD)-Dominant 3) By End User: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Sales Subsegments: 1) By High Tetrahydrocannabinol Capsules: Full-Spectrum Capsules, Isolate Capsules 2) By Tetrahydrocannabinol Or Cannabinol Balance Capsule: Ratio Capsules, Blend Capsules 3) By High Cannabinol Capsules: Full-Spectrum CBN Capsules, Isolate CBN CapsulesWhat Is The Driver Of The Cannabis Capsule Market?
The increasing number of neurological disorders is expected to propel the growth of the cannabis capsule market going forward. Neurological disorder refers to a medical condition affecting the central and peripheral nervous systems. It affects not just the spinal cord's and body's nerves but also the brain. Compounds found in cannabis capsules, such as cannabidiol (CBD), have potential beneficial effects for neurological disorders, as they are used to prevent the development of social recognition memory deficits in conditions such as Alzheimer's disease. For instance, in October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, more than 40% of the global population currently experiences some form of neurological condition, and this burden is expected to nearly double by 2050. Therefore, the increasing number of neurological disorders is driving the growth of the cannabis capsule industry.Key Players In The Global Cannabis Capsule Market
Major companies operating in the cannabis capsule market are GW Pharmaceuticals PLC, Trulieve Cannabis Corp., Green Thumb Industries Inc., Tilray Inc., Columbia Care Inc., Aphria Inc., Curaleaf Holdings Inc., Canopy Growth Corporation, Cresco Labs Inc., Aurora Cannabis Inc., Organigram Holdings Inc., Harvest Health & Recreation Inc., Cronos Group Inc., TerrAscend Corp., Vireo Health International Inc., Charlotte's Web Holdings Inc., The Valens Company Inc., Acreage Holdings Inc., Neptune Wellness Solutions Inc., CannTrust Holdings Inc., Valens Company Inc., HEXO Corp., Cann Group Limited, Plus Products Inc., Heritage Cannabis Holdings Corp., PharmaCielo Ltd., MediPharm Labs Corp., Sundial Growers Inc., MedReleaf Corp., Wana Brands
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Cannabis Capsule Market Trends and Insights
Major companies operating in the cannabis capsule market are focused on introducing innovative solutions, such as oral cannabis capsules, to gain a competitive edge in the market. An oral cannabis capsule is a form of cannabis consumption that involves encapsulating cannabis compounds, such as oil and decarboxylated flower, into pill form. For instance, in January 2023, Holistic Industries, a US-based organic medical cannabis company, launched CANNACEUTICA in the USA, the first oral cannabis capsule with dosing guidelines specifically formulated for and studied by people who suffer from chronic pain. It is a first-of-its-kind product and an alternative to opioids, with evidence and easy dosing guidelines. The oral cannabis pill comes with an Easy Dose Chart and easy dosing guidelines in each bottle to assist users in finding the optimal dose. The recommended starting dose is 2.5 milligrams of THC (Tetrahydrocannabinol).What Are Latest Mergers And Acquisitions In The Cannabis Capsule Market?
In February 2024, Aurora Cannabis Inc., a Canada-based producer of medical and consumer cannabis products, acquired MedReleaf Australia for an undisclosed amount. This acquisition is a strategic move for Aurora Cannabis aimed at expanding its market presence, enhancing performance, and solidifying its leadership in the global cannabis industry. MedReleaf Australia is an Australia-based manufacturer of medical cannabis products, including cannabis capsules.
Regional Insights
North America was the largest region in the cannabis capsule market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Cannabis Capsule Market?
The cannabis capsule market consists of sales of infused oil bases, isolated cannabinoids, and decarboxylated flowers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Cannabis Capsule Market Report 2026?
The cannabis capsule market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cannabis capsule industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Cannabis Capsule Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $55.59 billion |
| Revenue Forecast In 2030 | $108.48 billion |
| Growth Rate | CAGR of 18.3% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Type, Compound, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | GW Pharmaceuticals PLC, Trulieve Cannabis Corp., Green Thumb Industries Inc., Tilray Inc., Columbia Care Inc., Aphria Inc., Curaleaf Holdings Inc., Canopy Growth Corporation, Cresco Labs Inc., Aurora Cannabis Inc., Organigram Holdings Inc., Harvest Health & Recreation Inc., Cronos Group Inc., TerrAscend Corp., Vireo Health International Inc., Charlotte's Web Holdings Inc., The Valens Company Inc., Acreage Holdings Inc., Neptune Wellness Solutions Inc., CannTrust Holdings Inc., Valens Company Inc., HEXO Corp., Cann Group Limited, Plus Products Inc., Heritage Cannabis Holdings Corp., PharmaCielo Ltd., MediPharm Labs Corp., Sundial Growers Inc., MedReleaf Corp., Wana Brands |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |